Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.
Sector:
Non Energy Minerals
Industry:
Other Metals Or Minerals
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Clearmind Medicine Inc market cap is $1.33M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Clearmind Medicine Inc 52 week high is $648.00 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Clearmind Medicine Inc 52 week low is $2.63 as of November 22, 2026.
Clearmind Medicine Inc stock price today is $2.63.
Clearmind Medicine Inc stock price yesterday was $3.04.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Clearmind Medicine Inc P/B ratio is 0.0545.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Clearmind Medicine Inc 50-day moving average is $5.82.